The global pharmaceutical filtration market is evaluated at US$17.321 billion for the year 2019 growing at a CAGR of 11.67% reaching the market size of US$37.506 billion by the year 2026.
Increasing emphasis on biologics and their development for the treatment of various diseases is a major attribute expected to trigger growth. Pharmaceutical filtration is a separation process in which unwanted particles are separated from processed materials by passing them through a filtration membrane. This filtration process helps in separating suspended particles from a solution or medium. It offers extensive & significant sterile & nonsterile filtration of products in the pharmaceutical manufacturing industry. In addition, filters are used for removing contaminants such as particulate matter and microorganisms from solids, air, liquids, and gases. Furthermore, pharmaceutical filtration processes are widely used in several applications such as final product processing, water purification, raw material filtration, cell separation, and air purification.
Significant increase in the number of drug launches of generic medicines; rise in demand therapeutic biopharmaceuticals such as hormones, antibodies, and vaccines; technological advancements in nanofiltration technology; surge in demand for single-use technologies; rise in spending on R&D due to surge in government healthcare expenditure, and increase in the number of pharmaceutical and biopharmaceutical companies across the globe are some of the factors that drive the growth of the pharmaceutical filtration market during the forecast period. In addition, the rise in prevalence of chronic diseases, strong biologic pipeline products, and increase in demand for filters in the pharmaceutical and biopharmaceutical industry boost the pharmaceutical filtration market growth. Moreover, advantages offered by pharmaceutical filters such as low operating pressure, high speed, and low energy consumption further fuel the market growth.
However, low income and lack of proper medical attention, and large capital requirements in different countries are expected to restrain the growth of the market. On the contrary, the untapped potential offered by developing economies is expected to provide lucrative opportunities for market expansion during the forecast period.
Recently, there has been an increase in the adoption of single-use technologies. There have also been advancements in nanofiltration technologies, that has increased its demand in pharmaceutical filtration. Manufacturers have also increased their adherence to good manufacturing practices (GMP). Hence all these factors have hence helped the market growth.
The advent of COVID-19 had a positive impact on the pharmaceutical filtration market given the rise in its applications during the year. This type of filtration is also used in the air purifiers and water purifiers which were in high demand during the pandemic to curb the widespread of the disease and the rise in the scare. Due to the COVID-19 pandemic, stand-alone air purifiers are adopted by consumers for clean and virus-free air, which is likely to boost the global pharmaceutical filtration market in the coming years. With increasing sales of air purifiers and water purifiers, companies are launching new products. For instance, in July 2020, VironAire announced two affordable HEPA technology-based hospitals medical-grade air cleaners for hospitals, businesses, and homes. The market of pharmaceutical filtration is being driven by the high pollution levels, particularly in industrial countries in the Asia-Pacific region, increasing awareness about health issues associated with air and water pollution. With the growing population in urban areas where pollution is more intense, air and water purifiers are likely to grow.
Increasing cases of chronic diseases and a rise in investment in the healthcare sector are expected to fuel the market during the forecast period.
The increase in the number of chronic diseases globally is one of the prime reasons for the growth of the pharmaceutical industry. There is a high demand for advanced therapeutic drugs for the treatment of chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis.
Moreover, the production of novel biologics requires utmost sterility and zero risks of contamination which further necessitates the application of advanced filtration products for the manufacturing of drugs and biologics.
Increasing investment in the research and development of biologics is another prime factor attributing to the growth. The rapid adoption of innovative treatment therapies such as therapeutic proteins, monoclonal antibodies, and vaccines has resulted in an increased number of various biotechnology and biopharmaceutical companies that utilize filtration systems including membranes, cartridges, capsules, and other products. In addition, a large number of companies are investing heavily in manufacturing facilities worldwide. Thus, the growth in biopharmaceutical companies is projected to boost the demand for advanced products.
The technological progression by pharmaceutical filtration manufacturers has also resulted in the increasing adoption of these systems in the industry. The majority of the market players are constantly engaged in R&D to improve existing product portfolios and introduce novel technologies to aid in the sterilization of the media and the constituents.
|Market size value in 2019||US$17.321 billion|
|Market size value in 2026||US$37.506 billion|
|Growth Rate||CAGR of 11.67% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Filtration Type, Technology, Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||3M Company, Danaher Corporation, GE Healthcare, GEA Group, Graver Technologies, Merck Millipore, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Thermo Fisher Scientific|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the pharmaceutical filtration market?
A1. The global pharmaceutical filtration market is projected to grow at a CAGR of 11.67% during the forecast period.
Q2. How is the global pharmaceutical filtration market segmented?
A2. The pharmaceutical filtration market has been segmented based on filtration type, technology, application, and geography.
Q3. What will be the pharmaceutical filtration market size by 2026?
A3. The pharmaceutical filtration market is projected to reach a market size of US$37.506 billion in 2026.
Q4. What is the size of global pharmaceutical filtration market?
A4. Pharmaceutical Filtration Market was valued at US$17.321 billion in 2019.
Q5. What factors are anticipated to drive the pharmaceutical filtration market growth?
A5. Increasing emphasis on biologics and their development for the treatment of various diseases is a major attribute expected to trigger pharmaceutical filtration market growth.